A burgeoning field is launching its first clinical trial to find out whether dialing back cell development can safely refresh ...

From billionaire-backed biotech to promising animal studies, this early trial will test whether partial reprogramming can ...

Kazia Therapeutics Limited (Nasdaq: KZIA), a clinical-stage oncology company advancing therapies to reprogram cancer biology and overcome treatment resistance, announces the in-licensing of a first-in ...

Hoth Therapeutics, Inc. (NASDAQ: HOTH), a clinical-stage biopharmaceutical company, today announced positive data from its HT-VA study, conducted under its Cooperative Research and Development ...

Scientists at Life Biosciences are preparing to begin testing partial reprogramming in people. It will mark the first time ...

India, April 13 -- Life Biosciences, a clinical-stage biotechnology company focused on reversing diseases of aging, has received clearance from the U.S. Food and Drug Administration (FDA)-the ...

It is well known that students who prepare in advance perform better in exams. Now, it appears that the skin can do the same.

Human immunodeficiency virus-1 (HIV) is one of the most challenging viruses for doctors to treat. Even with effective ...

Early data suggests single-infusion treatment can safely reprogram immune cells inside the body, opening doors to more ...

Board of Alders New Haven Notice] The Joint Community Development/Health & Human Services Committee will meet in person on Wednesday, April 15, 2026, at 6:00 P.M, in the Board of Alders Chamber, 165 ...

Izzie Clarke: Hello and welcome to this Nature Custom Media podcast, supported by the Sigma-Aldrich® brand from Merck. I’m science journalist Izzie Clarke and in this episode, I explore how scientists ...

Lockheed Martin Corp. (NYSE:LMT) has secured two contract modifications from the U.S. Department of War totaling $91,867,982.